Neuromuscular Disorders
AAN 2026 highlights: key trial updates across narcolepsy, movement disorders, Tourette syndrome & more!
This episode of the VJNeurology Podcast showcases key trial updates from the American Academy of Neurology Annual Meeting in Chicago,…
Date: 5th May 2026
ALS Gene Therapy Insights with Prof. Dame Pamela Shaw
In recent years, genetic therapies have garnered much attention for their potential to modify the underlying pathological processes in neurological…
Date: 9th August 2024
Improving ALS management: diagnosis and treatment
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with highly variable clinical features and prognosis, making the diagnosis challenging. And…
Date: 9th September 2022
Complement inhibitors and FcRn antagonists for myasthenia gravis
Despite existing symptomatic, immunomodulatory, and immunosuppressive therapies, significant unmet needs in myasthenia gravis (MG) treatment remain. Advances in drug development…
Date: 19th August 2022
Clinical trials in neuromuscular disorders: ALS, MG & SMA
Over the past few years, a number of novel treatments for neuromuscular disorders were approved and are now available to…
Date: 21st February 2022
